Additionally, in older patients undergoing percutaneous coronary intervention, elevated sclerostin levels were associated with improved survival rates and fewer adverse cardiovascular events, which may be attributed to its role in mitigating the progression of atherosclerosis [31,40]. The gene discussed is SOST; the disease is atherosclerosis.